Obviously your post was to highlight the fact that Epadel in Japan maintained market share for a long time. Much of the stuff above is of course not very applicable now since the sales force was disbanded. If Amarin can hold onto sales in the U.S. (unfortunately it is a stagnant market) while conserving cash (other than share BB) long enough to get some traction in the EU, then there may be some hope staring us at the end of a very long dark tunnel.